Semaglutide is administered subcutaneously once weekly, and the needle is small, typically causing minimal pain
This produces multiple effects on metabolic pathways: Pancreatic and glycemic control [edit] Semaglutide enhances the growth and proliferation of pancreatic beta cells, which are responsible for insulin production, while mitigating oxidative stress to reduce cell death (apoptosis)
For chemical synthesis, innovation is focused on reducing solvent volumes, finding greener reagent alternatives, and redesigning the process to be less wasteful (e.g, flow chemistry, microwave-assisted SPPS)
And its rise has eclipsed the Danish economy, creating a lot of value on the one hand, but an imbalanced economy on the other
However, when announcing its OASIS 4 results, Novo Nordisk indicated that it expects to launch its higher-dose oral semaglutide treatment in the US in 2026